These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5811168)

  • 41. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW
    N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [HEMODYNAMIC FACTORS AFFECTING RENAL SECRETION OF ERYTHROPOIETIN. II. THE INCREASE OF PLASMATIC ERYTHROPOIETIN IN CARDIAC INSUFFICIENCY].
    PILIEGO N; ROSSINI P
    Rass Fisiopatol Clin Ter; 1963; 35():421-33. PubMed ID: 14069190
    [No Abstract]   [Full Text] [Related]  

  • 43. Erythropoiesis associated with viral hepatitis in end stage renal disease.
    Chan N; Barton CH; Mirahmadi MS; Gordon S; Vaziri ND
    Am J Med Sci; 1984; 287(1):56-8. PubMed ID: 6702889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 46. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 47. Platelet function in chronic renal failure.
    Bloom AL; Evans EP; Branch RA
    Acta Univ Carol Med Monogr; 1972; 53():333-8. PubMed ID: 4670739
    [No Abstract]   [Full Text] [Related]  

  • 48. [Kidney circulation in chronic parenchyma diseases and in kidney insufficiency].
    Buchali K; Zimmermann HB
    Z Urol Nephrol; 1977 May; 70(5):305-9. PubMed ID: 899309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A model for erythropoiesis in experimental chronic renal failure.
    Mason C; Thomas TH
    Br J Haematol; 1984 Dec; 58(4):729-40. PubMed ID: 6518138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effects of ninzin-to with daiokanso-to in patients with chronic renal failure].
    Nishio S; Hayashi S; Yoshihara H
    Hinyokika Kiyo; 1988 Oct; 34(10):1837-40. PubMed ID: 3245530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides.
    Bohle A; Müller GA; Wehrmann M; Mackensen-Haen S; Xiao JC
    Kidney Int Suppl; 1996 May; 54():S2-9. PubMed ID: 8731185
    [No Abstract]   [Full Text] [Related]  

  • 52. Anaemia in renal disease.
    Pryor JS; Joekes AM
    Br J Urol; 1969 Aug; ():Suppl:88-96. PubMed ID: 5810520
    [No Abstract]   [Full Text] [Related]  

  • 53. [Secondary gout, 6-years after acute renal failure].
    Mertz DP; Schindera F
    Dtsch Med Wochenschr; 1968 May; 93(18):908-12. PubMed ID: 5646132
    [No Abstract]   [Full Text] [Related]  

  • 54. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.
    Locatelli F; Aljama P; Bárány P; Canaud B; Carrera F; Eckardt KU; Hörl WH; Macdougal IC; Macleod A; Wiecek A; Cameron S;
    Nephrol Dial Transplant; 2004 May; 19 Suppl 2():ii1-47. PubMed ID: 15206425
    [No Abstract]   [Full Text] [Related]  

  • 55. Erythropoietin and anemia in chronic renal failure.
    Pavlović-Kentera V; Clemons GK; Djukanović L; Biljanović-Paunovic L
    Exp Hematol; 1987 Aug; 15(7):785-9. PubMed ID: 3609182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indirect assessment of left ventricular function following hemodialysis in patients with chronic renal disease.
    Prakash R; Wegner S
    Am J Med Sci; 1972 Aug; 264(2):127-33. PubMed ID: 4653116
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis].
    Pietrzyk JA; Smolnik T; Szymowska M; Dyras P; Lenik J
    Przegl Lek; 1992; 49(1-2):55-60. PubMed ID: 1455008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis].
    Kawamura J; Okabe T; Yamashita A; Sawanishi K; Katõ T
    Hinyokika Kiyo; 1971 Mar; 17(3):157-86. PubMed ID: 5103947
    [No Abstract]   [Full Text] [Related]  

  • 59. Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.
    Warren DJ; Swainson CP; Wright N
    Br Med J; 1974 Apr; 2(5912):193-4. PubMed ID: 4832235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Administration of stroma-free haemoglobin solution.
    Rudowski W; Schier J; Daszyński J; Kostrzewska E
    Haematologia (Budap); 1972; 6(4):409-18. PubMed ID: 4670115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.